Series E - FogPharma

Series E - FogPharma

Investment Firm

Overview

FogPharma is a biopharmaceutical firm that develops precision medicines for the vast majority of therapeutic targets.

Announced Date

Mar 01, 2024

Closed on Date

Mar 01, 2024

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

Nextech Invest

Nextech Invest

Nextech Invest is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

19

Investor Name
Participant InvestorGoogle Ventures
Participant InvestorARCH Venture Partners
Participant InvestorGeneral Catalyst
Participant InvestorFidelity
Participant InvestorFarallon Capital Management

Round Details and Background

FogPharma raised $145000000 on 2024-03-01 in Series E

FogPharma is a biopharmaceutical firm that develops precision medicines for the vast majority of therapeutic targets.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 21, 2022
Series D - FogPharma
13-178.0M
Jan 04, 2021
Venture Round - FogPharma
-23.3M
Mar 01, 2024
Series E - FogPharma
20-145.0M
Jun 07, 2016
Series A - FogPharma
1-11.0M

Recent Activity

There is no recent news or activity for this profile.